Enovis (ENOV) Gross Margin Growth (5y) (2015 - 2026)
Enovis (ENOV) Gross Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 698.00 |
| Dec 31, 2025 | 1,786.00 |
| Oct 3, 2025 | 1,722.00 |
| Jul 4, 2025 | 2,042.00 |
| Apr 4, 2025 | 1,680.00 |
| Dec 31, 2024 | 1,026.00 |
| Sep 27, 2024 | 1,321.00 |
| Jun 28, 2024 | 1,362.00 |
| Mar 29, 2024 | 1,954.00 |
| Dec 31, 2023 | 2,652.00 |
| Sep 29, 2023 | 2,551.00 |
| Jun 30, 2023 | 2,374.00 |
| Mar 31, 2023 | 2,326.00 |
| Dec 31, 2022 | 2,608.00 |
| Sep 30, 2022 | 2,498.00 |
| Jul 1, 2022 | 2,421.00 |
| Apr 1, 2022 | 2,215.00 |
| Dec 31, 2021 | 2,133.00 |
| Oct 1, 2021 | 2,389.00 |
| Jul 2, 2021 | 2,513.00 |